Clinical Trials Logo

Disease clinical trials

View clinical trials related to Disease.

Filter by:

NCT ID: NCT02662803 Completed - Clinical trials for Generalized Anxiety Disorder (GAD)

Clinical, Neurophysiological and Neuroendocrine Effects of Aerobe Exercise in Generalized Anxiety Disorder (GAD)

GAD_exercise
Start date: January 2015
Phase: N/A
Study type: Interventional

This study investigate the effect of high-intense aerobe exercise training (HIT) on clinical and physiological parameters (anxiety, somatisation, cortisol, alpha amylase, "mismatch negativity", loudness dependence auditory evoked potentials) in patients with generalized anxiety disorder (GAD). Half of patients will receive HIT, while the other half will receive aerobe exercise of low intensity.

NCT ID: NCT02661828 Terminated - Clinical trials for Major Depressive Disorder

Tapering Off Antidepressants

Start date: January 2016
Phase: N/A
Study type: Interventional

The purpose of this study is to compare two ways to stop taking an antidepressant medication and determine whether a faster or slower taper is better tolerated.

NCT ID: NCT02661061 Terminated - Depression Clinical Trials

Ketamine for Relapse Prevention in Recurrent Depressive Disorder

KINDRED
Start date: December 2015
Phase: Phase 1
Study type: Interventional

Randomised, controlled, parallel-group, pilot clinical trial of ketamine vs. midazolam for depression relapse prevention in persons at high risk. The main purpose of the pilot study is to assess trial processes to help inform a future definitive trial.

NCT ID: NCT02660385 Completed - Pain Clinical Trials

Insomnia Self-Management in Heart Failure

HSS
Start date: March 7, 2016
Phase: N/A
Study type: Interventional

Chronic insomnia may contribute to the development and exacerbation of heart failure (HF), incident mortality and contributes to common and disabling symptoms (fatigue, dyspnea, anxiety, depression, excessive daytime sleepiness, and pain) and decrements in objective and subjective functional performance. The purposes of the study are to evaluate the sustained effects of CBT-I on insomnia severity, sleep characteristics, daytime symptoms, and functional performance over twelve months among patients who have stable chronic HF and chronic insomnia. The effects of the treatment on outcomes of HF (hospitalization, death) and costs of the treatment will also be examined. A total of 200 participants will be randomized to 4 bi-weekly group sessions of cognitive behavioral therapy for CBT-I (behavioral was to improve insomnia and sleep) or HF self-management education. Participants will complete wrist actigraph (wrist-watch like accelerometer) measures of sleep, diaries, reaction time, and 6 minute walk test distance. They will also complete self-report measures of insomnia, sleep, symptoms, and functional performance. In addition the effects on symptoms and function over a period of one year.

NCT ID: NCT02660099 Completed - Clinical trials for Autism Spectrum Disorder

Internet Delivered CBT for OCD in Adolescents With ASD - A Clinical Case Series

Start date: July 2015
Phase: N/A
Study type: Interventional

The aim of this study is to test the feasibility and acceptability of an internet-delivered cognitive behavior therapy (ICBT) intervention originally developed for neurotypical adolescents with obsessive compulsive disorder (OCD) in adolescents with OCD and autism spectrum disorder (ASD). This feasibility study will inform us how to adapt the original intervention to the specific needs of patients with ASD.

NCT ID: NCT02659475 Completed - Clinical trials for Binge Eating Disorder

Phentermine/Topiramate Extended Release in Binge Eating Disorder (BED)

Start date: September 2015
Phase: Phase 2
Study type: Interventional

The goal of this project is to evaluate the effectiveness and tolerability of the novel weight management medication PHEN/TPM ER (Qsymia®)along with nutritional and lifestyle modification counseling in the treatment of binge eating disorder (BED) in overweight or obese individuals.

NCT ID: NCT02659436 Completed - Clinical trials for Social Anxiety Disorder

Imagery-based CBT for Social Anxiety Disorder: Piloting a Treatment Augmentation Protocol

Start date: January 2016
Phase: N/A
Study type: Interventional

The purpose of this pilot study is to explore whether there is a differential impact of verbal versus imagery-based cognitive behavioural therapy (CBT) as a treatment augmentation strategy for individuals with social anxiety disorder (SAD). Clients who have not demonstrated clinically significant change following group CBT for SAD will receive four additional sessions of either verbal-based CBT or imagery-based CBT. We hypothesize that that individuals who receive imagery-based CBT will experience even stronger improvements and be more satisfied with their treatment than individuals who received traditional verbal-linguistic CBT.

NCT ID: NCT02659085 Completed - Clinical trials for Depressive Disorder, Major

Ketamine as an Alternative Treatment to ECT in Major Depressive Disorder

Start date: February 2015
Phase: Phase 2/Phase 3
Study type: Interventional

Developing more effective and faster acting antidepressant is of outmost clinical importance. Available antidepressant therapies have a delayed therapeutic effect. It typically takes several weeks before symptom relief is evident. Furthermore, antidepressants are relatively ineffective - as many as 30% of patients do not respond to any medication at all. In this study the investigators evaluate the NMDA-receptor antagonist ketamine as a potentially new antidepressant treatment for severely depressed patients and compare its effectiveness with that of electroconvulsive therapy (ECT).

NCT ID: NCT02657980 Completed - Clinical trials for Major Depressive Disorder

The Effect of tDCS in Patients With Moderate to Severe Major Depressive Disorder

Start date: April 2015
Phase: Phase 3
Study type: Interventional

Study Type: Interventional Study Design: Allocation: Randomized Endpoint Classification: Safety/Efficacy Study Intervention Model: Parallel Assignment Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor) Primary Purpose: Treatment

NCT ID: NCT02657317 Completed - Depression Clinical Trials

Establishing Efficacy of a Functional-Restoration Based CAM Pain Management Program in Post-9/11 Veterans

Start date: April 4, 2016
Phase: N/A
Study type: Interventional

This is a research study of an interdisciplinary pain management program for U.S. military veterans who served during the post-9/11 combat eras (e.g., Operations Iraqi Freedom [OIF], Enduring Freedom [OEF], New Dawn [OND]) presenting with chronic musculoskeletal pain related to military service with comorbid depression and/or posttraumatic stress disorder [PTSD] symptoms and/or mild traumatic brain injury. This study will test the efficacy of an interdisciplinary pain program compared to treatment as usual in the Veterans Health Administration on pain-related disability, opioid medication use, and pain coping.